WestEnd Advisors’s Clorox CLX Stock Holding History

WestEnd Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$622	–	415
2026 Q1	$622	Hold	6	–	–	﹤0.01%	294
2025 Q4	$605	Buy	6 +1	+20%	+$109	﹤0.01%	293
2025 Q3	$617	Buy	5 +1	+25%	+$124	﹤0.01%	282
2025 Q2	$480	Hold	4	–	–	﹤0.01%	279
2025 Q1	$589	Buy	4 +3	+300%	+$458	﹤0.01%	259
2024 Q4	$162	Hold	1	–	–	﹤0.01%	281
2024 Q3	$163	Hold	1	–	–	﹤0.01%	310
2024 Q2	$136	Hold	1	–	–	﹤0.01%	302
2024 Q1	$153	Sell	1 -1	-50%	-$149	﹤0.01%	269
2023 Q4	$285	Hold	2	–	–	﹤0.01%	202
2023 Q3	$262	Buy	+2	New	+$304	﹤0.01%	206
2023 Q1	–	Sell	-1	Closed	-$150	–	196
2022 Q4	$140	Hold	1	–	–	﹤0.01%	256
2022 Q3	$0	Buy	+1	New	+$144	﹤0.01%	170

Other funds holding CLX

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CWA

Canvas Wealth Advisors Shawnee, Kansas $717M AUM 41.56% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

WestEnd Advisors's CLX Position: Q2 2026 in Review

WestEnd Advisors sold out of Clorox (CLX) in Q2 2026, closing a stake of 6 shares — an estimated $622 sold.

WestEnd Advisors first reported a position in CLX in Q3 2022 and held it in 13 quarters. The position peaked at $622 in Q1 2026. 286 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

WestEnd Advisors reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
WestEnd Advisors sold 6 Clorox shares in Q2 2026, an estimated $622.
WestEnd Advisors first reported a position in Clorox in Q3 2022 and held it in 13 quarters.
WestEnd Advisors's Clorox position peaked at $622 in Q1 2026.
286 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.